{
    "title": "EU agency recommends AstraZeneca-Merck drug Lynparza for two cancers",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8754769/AstraZeneca-Mercks-Lynparza-wins-EU-panel-recommendation-cancer-treatments.html",
    "date": "2020-09-21",
    "keywords": [
        "cancer",
        "approval",
        "prostate",
        "recommendation",
        "lynparza",
        "form",
        "astrazeneca",
        "pushkala",
        "aripaka",
        "ema",
        "treatment",
        "drug",
        "parp",
        "use",
        "zejula",
        "aakash",
        "b",
        "agency",
        "maintenance",
        "drugmaker",
        "secondmost",
        "type",
        "cause",
        "death",
        "europe",
        "merck",
        "inc",
        "competition",
        "glaxosmithkline",
        "focus",
        "research",
        "breast",
        "lung",
        "week",
        "inhibitor",
        "eu",
        "watchdog",
        "option",
        "bay",
        "class",
        "dna",
        "thereby",
        "clovis",
        "oncology",
        "committee",
        "cmph",
        "july",
        "commission",
        "couple",
        "latestage",
        "trial",
        "half",
        "reporting",
        "jagadeesh",
        "babu",
        "bengaluru",
        "editing",
        "chakrabarty",
        "alexander",
        "smith"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}